Document Detail

Changing the practice of cardiovascular medicine.
MedLine Citation:
PMID:  11286153     Owner:  NLM     Status:  MEDLINE    
Five large randomized trials of statins in primary and secondary prevention show the benefits of lipid-modifying therapy on cardiac morbidity and mortality. Evidence is beginning to accumulate showing that early and aggressive treatment of patients with acute coronary syndromes (acute myocardial infarction or unstable angina) can result in reduced mortality and morbidity and imparts a variety of mechanistic benefits. Nevertheless, recent surveys of coronary heart disease prevention in Europe and the US indicate that current evidence-based management of risk factors such as hypercholesterolemia is not uniformly employed. In fact, in Europe, only about a third of patients discharged from the hospital after an acute coronary syndrome are receiving prescriptions for statins. In US, more than a fourth of adults are eligible for treatment according to national guidelines but two thirds of them do not receive it. Among those treated, a considerable number do not reach their target levels. Therefore, strategies are needed to improve prescribing patterns among physicians and compliance among patients. It is essential that clinicians be aware of the evidence base supporting early and aggressive treatment of patients with acute coronary syndromes and that this is communicated to all clinicians involved in their care of patients with acute coronary syndromes.
E Braunwald
Related Documents :
1486543 - Regression growth evaluation statin study (regress): study design and baseline characte...
20549843 - Lipid-lowering drugs and heart failure: where do we go after the statin trials?
7196603 - Echocardiography in combined discrete and hypertrophic subaortic stenosis.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Atherosclerosis. Supplements     Volume:  2     ISSN:  1567-5688     ISO Abbreviation:  Atheroscler Suppl     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-04-04     Completed Date:  2001-07-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  100973461     Medline TA:  Atheroscler Suppl     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  27-30     Citation Subset:  IM    
Department of Medicine, Harvard Medical School, Prudential Tower, Suite 1150, 800 Boylston Street, Boston, MA 02190, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Anticholesteremic Agents / therapeutic use*
Coronary Disease / drug therapy*,  prevention & control*
Middle Aged
Patient Compliance*
Physician's Practice Patterns*
Randomized Controlled Trials as Topic
Risk Factors
Reg. No./Substance:
0/Anticholesteremic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical relevance of statins: their role in secondary prevention.
Next Document:  The treatment potential in preventive cardiology.